During the past decade, Stortorgets neurologmottagning conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Stortorgets neurologmottagning" are "Cervical Dystonia" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Stortorgets neurologmottagning" in a lesser frequency.

Most popular intervention types in "Stortorgets neurologmottagning" are "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum toxin type A" (1 trials), "Chordate System S200 + CT100 (active treatment)" (1 trials) and "Chordate System S200 + CT100 (placebo treatment)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stortorgets neurologmottagning" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Stortorgets neurologmottagning". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Stortorgets neurologmottagning, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stortorgets neurologmottagning, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".